skip to navigation skip to content skip to footer

External Sites

World Health Organization (WHO)

The WHO Global Malaria Programme (GMP) is responsible for the coordination of WHO's global efforts to control and eliminate malaria. The GMP sets evidence-based norms, standards, policies and guidelines to support malaria-affected countries around the world.

More information is available from: http://www.who.int/malaria/en/

United States Centers for Disease Control (CDC)

The US Centers for Disease Control provides expert advice on the prevention and treatment of malaria. It has a long history of collaboration with partners across the world and provides technical expertise in policy development, program guidance and support, scientific research, and monitoring and evaluation of progress.

More information is available from:http://www.cdc.gov/malaria/

The United Kingdom Public Health England (PHE) Advisory Committee on Malaria Prevention

The UK PHE Advisory Committee on Malaria Prevention provides guidelines for healthcare workers who advise travellers and are often used by prospective travellers to inform themselves of various options.

More information is available from: https://www.gov.uk/government/publications/malaria-prevention-guidelines-for-travellers-from-the-uk

Malaria for long-term & expatriate workers

Travel Doctor – TMVC is an Australian civilian company that provides service to all travellers, before travel, whilst travelling and on return.  It provides a variety of facts sheets including one on malaria for long-term & expatriate workers.

More information is available from: http://www.traveldoctor.com.au/Page/Knowledge-Hub/Tropical-disease-facts/Malaria-for-long-term-and-expatriate-workers

Senate inquiry into the mental health of ADF serving personnel

The Senate, Foreign Affairs, Defence and Trade Reference Committee recently inquired into the mental health of Australian Defence Force (ADF) members and veterans. Submissions and hearings included concerns relating to the use of mefloquine in the ADF.

More information is available from: http://www.aph.gov.au/Parliamentary_Business/
Committees/Senate/Foreign_Affairs_Defence_and_Trade/ADF_Mental_Health

The United Kingdom House of Commons Defence Committee – Lariam inquiry

The Defence Committee recently conducted an inquiry into the use of Lariam / mefloquine in the UK Armed Forces. The inquiry concentrated on:

  • The UK Ministry of Defence (MoD) policy of prescribing Lariam to military personnel and the practice and policy of other nations;
  • The effectiveness of Lariam and alternative anti-malarial drugs;
  • Assessments of the safety of Lariam conducted by the MoD and other organisations;
  • The accuracy of reports highlighting adverse side-effects of using Lariam; and
  • The Department's policy for dealing with military personnel who have suffered from detrimental side effects of using Lariam.

The recommendations made in the subsequent report were very much in line with the policy the ADF has had in relation to mefloquine for some years.

More information is available from: http://www.parliament.uk/business/committees/committees-a-z/commons-select/defence-committee/inquiries/parliament-2015/inquiry/

Canadian Department of National Defence – Review on the operational use of mefloquine in the Canadian Armed Forces

The Surgeon General’s Task Force Report on Mefloquine provides a detailed overview of the Canadian Armed Forces’ (CAF) history and experiences using mefloquine for malaria chemoprophylaxis, including an analysis of mefloquine prescribing practices in the CAF. It also features a detailed analysis of international/national/military guidelines for malaria prevention through chemoprophylaxis recommendations, and an evidence review of the tolerability/safety of mefloquine for military personnel compared to alternatives.

The recommendations made in the report included a change to the CAF policy on malaria prevention to ensure mefloquine is only used when alternative medications are unsuitable. This recommendation is very much in line with the policy the ADF has had in relation to mefloquine for some years.

More information is available from: http://www.forces.gc.ca/en/about-reports-pubs-health/surg-gen-rpt-mefloquine.page